Medical Decision Modeling (United States)
- Research works
- 89 ▼ 18% vs 2013–17
- Citations
- 2.1k 24.2 per fractional work
- Top-10% rate
- 12.9% record average 16.5%
- Open access
- 40% world 28%
Not ranked overall: Medical Decision Modeling (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 7.7×. Every wedge is a field page.
- Economics, Econometrics and Finance 7.7×
- Medicine 2.5×
- Immunology and Microbiology 1.6×
- Materials Science 1.4×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Health Professions 0.8×
- Neuroscience 0.7×
- Social Sciences 0.7×
- Chemistry 0.6×
- Physics and Astronomy 0.5×
- Mathematics 0.3×
- Engineering 0.3×
- Computer Science 0.3×
- Business, Management and Accounting 0.2×
- Environmental Science 0.2×
- Psychology 0.1×
Which keywords describe research at Medical Decision Modeling (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Glycemic Control, Insulin Therapy, Metabolic Syndrome, Complications and Cardiovascular Disease.
- Type 2 Diabetes
- Cardiovascular Outcomes
- Molecular Characterization
- Bayesian Methods
- Primary Care
- Autoantibodies
- Chemotherapy
- Financial Toxicity
- Clinical Guidelines
- Biomarkers
- Continuous Glucose Monitoring
- Cardiovascular Risk
- Risk Factors
- Headache Disorders
- Diabetes
- Complications
- Inflammation
- Glycemic Control
- Epidemiology
- Cost-effectiveness Analysis
- Quality of Life
- Health Utility Measures
- Cardiovascular Disease
- Insulin Therapy
- Metabolic Syndrome
- Neurological Disorders
- Genetic Influences
- Migraine
- Clinical Trials
- Targeted Therapy
- Hypoglycemia
- Hypertension
- Cost of Care
- Heart Failure
- Guidelines
- Treatment Guidelines
- 3D Printing
- Breast Cancer
- Adaptive Designs
- False Discovery Rate
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life9▲ 7.2×11 topics
- Cost-effectiveness Analysis6▲ 91×1 topic
- Health Utility Measures6▲ 91×1 topic
- Epidemiology6▲ 1.61×31 topics
- Cardiovascular Disease4▲ 4.4×8 topics
- Glycemic Control4▲ 36×4 topics
- Insulin Therapy4▲ 45×3 topics
- Inflammation4▲ 2.0×15 topics
- Metabolic Syndrome4▲ 5.5×10 topics
- Complications4▲ 8.0×5 topics
- Neurological Disorders4▲ 5.9×4 topics
- Diabetes3▲ 7.5×4 topics
- Genetic Influences3▲ 62×2 topics
- Headache Disorders3▲ 145×1 topic
- Migraine3▲ 80×1 topic
- Risk Factors3▲ 3.3×10 topics
- Clinical Trials3▲ 5.2×9 topics
- Cardiovascular Risk3▲ 9.0×6 topics
- Targeted Therapy3▲ 14×3 topics
- Continuous Glucose Monitoring3▲ 66×1 topic
- Hypoglycemia3▲ 66×1 topic
- Biomarkers2▲ 4.4×6 topics
- Hypertension2▲ 7.7×4 topics
- Clinical Guidelines2▲ 8.4×3 topics
- Cost of Care2▲ 137×1 topic
- Financial Toxicity2▲ 137×1 topic
- Heart Failure2▲ 5.7×5 topics
- Chemotherapy2▲ 3.5×7 topics
- Guidelines2▲ 5.3×4 topics
- Autoantibodies2▲ 9.9×2 topics
- Treatment Guidelines2▲ 10×3 topics
- Primary Care2▲ 5.0×6 topics
- 3D Printing2▲ 11×2 topics
- Bayesian Methods2▲ 35×2 topics
- Breast Cancer2▲ 7.2×6 topics
- Molecular Characterization2▲ 9.8×3 topics
- Adaptive Designs2▲ 69×1 topic
- Cardiovascular Outcomes2▲ 41×1 topic
- False Discovery Rate2▲ 69×1 topic
- Type 2 Diabetes2▲ 9.4×1 topic
Which research topics does Medical Decision Modeling (United States) publish most on?
By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer and Advanced Breast Cancer Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 3 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 6 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 7 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 8 Machine Learning in Materials Science Materials Chemistry 0 works
- 9 Military Technology and Strategies Aerospace Engineering 0 works
- 10 Legal and Regulatory Analysis Transportation 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Medical Decision Modeling (United States)'s research output changed?
Output in 2018–2022 was 18% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Indianapolis
- Indiana University – Purdue University Indianapolis
- Eli Lilly (United States)
- University of Indianapolis
- Butler University
- Indiana University Health
- Indianapolis Zoo
- Riley Hospital for Children
- Methodist Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.